11/10/15Anavex 2-73 prospective Alzheimer's Disease treatment shows cognitive improvement in patients
win-win huge market with tons of revenue or buyout.
If you follow GPRO you will know that the CEO made personal announcement stating sales are strong. Many don't bother doing the DD and will be surprised when they beat earnings.
By the time there is a run-up for ER, Upgrades before ER and After ER and expected sales in $billions on their new Cystic Fibrosis drug that will be announced for the first time at up coming earmings..back to $140's is not out of the question.
At this price probably a buyout target, Roger Newton creator of ESPR and Scientific Officer , he Created Lipitor.